Emerging Agents in the Pipeline for Merkel Cell Carcinoma

2 Bekeken
administrator
administrator
07/17/23

Howard L. Kaufman, MD, FACS, chief surgical officer and associate director for clinical science at Rutgers Cancer Institute of New Jersey, discusses emerging agents in the pipeline for Merkel cell carcinoma.

  • categorie

Laat meer zien

0 Comments Sorteer op

Geen reacties gevonden

Facebook Reacties

Volgende